Glycorex Transplantation AB (publ) earnings
Annual earnings per share (SEK per share, as reported)
| Fiscal year | Period end | Diluted EPS | Basic EPS | Filed |
|---|---|---|---|---|
| 2024 | 2024-12-31 | SEK -0.15 | SEK -0.15 | 2026-06-19T06:10:01Z |
| 2023 | 2023-12-31 | SEK -0.41 | SEK -0.41 | 2026-06-19T06:10:01Z |
Revenue & profit (SEK)
| Concept | 2024 | 2023 |
|---|---|---|
| Revenue | — | — |
| Profit for the year | -SEK 10.9M | -SEK 30.4M |
Methodology
Earnings per share comes from ifrs-full:DilutedEarningsLossPerShare /
ifrs-full:BasicEarningsLossPerShare; revenue from
ifrs-full:Revenue and profit from ifrs-full:ProfitLoss,
as tagged in Glycorex Transplantation AB (publ)'s ESEF annual reports (source:
filings.xbrl.org).
Figures are in SEK, as reported. Not investment advice.